Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party
Author(s):
Sobh, M.; Michallet, M.; Dubois, V.; Iacobelli, S.; Koster, L.; Biezen, A. van; Fegueux, N.; Tabrizi, R.; Finke, J.; El-Cheikh, J.; Schipperus, M.; Meijer, E.; Borne, P. von dem; Petersen, E.; Russell, N.; Tholouli, E.; Passweg, J.; Garban, F.; Maertens, J.; Chevalier, P.; Maillard, N.; Volin, L.; Francois, S.; Lioure, B.; Beguin, Y.; Gluckman, E.; Ruggeri, A.; Garderet, L.; Kroger, N.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-07-31
Language
English
Is part of
Haematologica (2017), Vol. 102, no. 7, p. E271-E274
